Bio

Matthew Byron focuses his strategic M&A practice on representing public and private companies as well as private equity sponsors in a broad range of industries, including life sciences, technology, consumer brands, infrastructure and financial services. Matt has led recent transactions for Johnson & Johnson, Vertex Pharmaceuticals, Toast, Ginkgo Bioworks, EMCOR, Heidelberg Materials, Planet Fitness, and TSG Consumer Partners.